CCL2‐CCR2 signaling axis in obesity and metabolic diseases
Journal of Cellular Physiology · 2024-04 · 239 (4)
DOI: 10.1002/jcp.31192 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, online erschienen am 29.01.2024. Verfasst von Yue Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Animal Resistance Biology, Center for Cell Structure and Function, Collaborative Innovation Center of Cell Biol…. Hauptthemen laut MEDLINE: Metabolic Diseases, Obesity, Receptors, CCR2. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 144 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Obesity and metabolic diseases, such as insulin resistance, type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular ailments, represent formidable global health challenges, bearing considerable implications for both morbidity and mortality rates. It has become increasingly evident that chronic, low‐grade inflammation plays a pivotal role in the genesis and advancement of these conditions. The involvement of C‐C chemokine ligand 2 (CCL2) and its corresponding receptor, C‐C chemokine receptor 2 (CCR2), has been extensively documented in numerous inflammatory maladies. Recent evidence indicates that the CCL2/CCR2 pathway extends beyond immune cell recruitment and inflammation, exerting a notable influence on the genesis and progression of metabolic syndrome. The present review seeks to furnish a comprehensive exposition of the CCL2‐CCR2 signaling axis within the context of obesity and metabolic disorders, elucidating its molecular mechanisms, functional roles, and therapeutic implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory of Animal Resistance Biology, Center for Cell Structure and Function, Collaborative Innovation Center of Cell Biology in Universities of Shandong, College of Life Sciences, Shandong No…
ORCID-Profile: Yue Wu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wu, Y., & Ma, Y. (2024). CCL2‐CCR2 signaling axis in obesity and metabolic diseases. Journal of Cellular Physiology, 239(4). https://doi.org/10.1002/jcp.31192
Vancouver
Wu Y, Ma Y. CCL2‐CCR2 signaling axis in obesity and metabolic diseases. Journal of Cellular Physiology. 2024;239(4). doi:10.1002/jcp.31192
BibTeX
@article{Wu2024,
author = {Wu, Yue and Ma, Yanchun},
title = {CCL2‐CCR2 signaling axis in obesity and metabolic diseases},
journal = {Journal of Cellular Physiology},
year = {2024},
volume = {239},
number = {4},
doi = {10.1002/jcp.31192}
}
EUVIMED